The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Celltrion
Stock and Other Ownership Interests - Celltrion
Travel, Accommodations, Expenses - Celltrion
Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC).
 
Justin Stebbing
Consulting or Advisory Role - Celltrion
 
Yauheni Valerievich Baranau
No Relationships to Disclose
 
Valery Baryash
No Relationships to Disclose
 
Alexey Manikhas
No Relationships to Disclose
 
Vladimir Moiseyenko
No Relationships to Disclose
 
Giorgi Dzagnidze
Research Funding - A&Z Pharmaceutical; Celltrion; Roche
 
Edvard Javrid
No Relationships to Disclose
 
Dmytro Boliukh
No Relationships to Disclose
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Joanna Pikiel
No Relationships to Disclose
 
Alexandru E. Eniu
Research Funding - AstraZeneca; Celltrion; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche; Teva
 
Dmitry Komov
No Relationships to Disclose
 
Zakaria Zautashvili
No Relationships to Disclose
 
Gabriela Morar-Bolba
Consulting or Advisory Role - Pierre Fabre
Travel, Accommodations, Expenses - Roche
 
Rubi Khaw Li
Research Funding - AstraZeneca; Celltrion; GlaxoSmithKline; Novartis; Pfizer
 
Igor Lifirenko
No Relationships to Disclose
 
Andriy V. Rusyn
No Relationships to Disclose
 
Sang Joon Lee
Employment - Celltrion
Leadership - Celltrion
Stock and Other Ownership Interests - Celltrion
Travel, Accommodations, Expenses - Celltrion
 
Sung Young Lee
No Relationships to Disclose
 
Francisco J. Esteva
Consulting or Advisory Role - Celgene; Celltrion; Genentech/Roche; NanoString Technologies; Novartis; Spectrum Pharmaceuticals
Research Funding - Kadmon (Inst); Merrimack (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Myriad Genetics (royalties)
Travel, Accommodations, Expenses - Novartis